LINC01232 通过 p300/H3K27ac 促进 ARNTL2 的转录激活并抑制 CRC 细胞的铁变态反应。

IF 3 4区 医学 Q2 GENETICS & HEREDITY
Epigenomics Pub Date : 2024-01-01 Epub Date: 2024-09-13 DOI:10.1080/17501911.2024.2387528
Shengwei Zhuang, Zhekun Huang, Hongkai Fan, Zhirong Wu, Han Liu
{"title":"LINC01232 通过 p300/H3K27ac 促进 ARNTL2 的转录激活并抑制 CRC 细胞的铁变态反应。","authors":"Shengwei Zhuang, Zhekun Huang, Hongkai Fan, Zhirong Wu, Han Liu","doi":"10.1080/17501911.2024.2387528","DOIUrl":null,"url":null,"abstract":"<p><p><b>Aim:</b> This study investigated the role of lncRNA <i>LINC01232</i> in ferroptosis of colorectal cancer (CRC).<b>Materials & methods:</b> Real time quantitative polymerase chain reaction or western blot experiments were performed to examine relevant mRNAs and proteins expression. The kit assays evaluated malondialdehyde, iron, Fe<sup>2+</sup> and glutathione levels. ROS levels were verified by flow cytometry. Chromatin immunoprecipitation and RNA immunoprecipitation analysis monitored the correlation among <i>LINC01232</i>, H3K27ac, p300 and ARNTL2.<b>Results:</b> <i>LINC01232</i> or <i>ARNTL2</i> knockdown facilitated erastin-induced ferroptosis. The interaction between <i>LINC01232</i> and p300 resulted in the enhancement of H3K27ac levels at <i>ARNTL2</i> promoter to promote <i>ARNTL2</i> transcriptional activity. <i>ARNTL2</i> overexpression reversed the promoting effect of <i>LINC01232</i> knockdown on ferroptosis.<b>Conclusion:</b> <i>LINC01232</i> inhibited the ferroptosis in CRC by epigenetically upregulating the transcriptional activity of <i>ARNTL2</i>.</p>","PeriodicalId":11959,"journal":{"name":"Epigenomics","volume":"16 15-16","pages":"1097-1115"},"PeriodicalIF":3.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11418281/pdf/","citationCount":"0","resultStr":"{\"title\":\"<i>LINC01232</i> promotes <i>ARNTL2</i> transcriptional activation and inhibits ferroptosis of CRC cells through p300/H3K27ac.\",\"authors\":\"Shengwei Zhuang, Zhekun Huang, Hongkai Fan, Zhirong Wu, Han Liu\",\"doi\":\"10.1080/17501911.2024.2387528\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Aim:</b> This study investigated the role of lncRNA <i>LINC01232</i> in ferroptosis of colorectal cancer (CRC).<b>Materials & methods:</b> Real time quantitative polymerase chain reaction or western blot experiments were performed to examine relevant mRNAs and proteins expression. The kit assays evaluated malondialdehyde, iron, Fe<sup>2+</sup> and glutathione levels. ROS levels were verified by flow cytometry. Chromatin immunoprecipitation and RNA immunoprecipitation analysis monitored the correlation among <i>LINC01232</i>, H3K27ac, p300 and ARNTL2.<b>Results:</b> <i>LINC01232</i> or <i>ARNTL2</i> knockdown facilitated erastin-induced ferroptosis. The interaction between <i>LINC01232</i> and p300 resulted in the enhancement of H3K27ac levels at <i>ARNTL2</i> promoter to promote <i>ARNTL2</i> transcriptional activity. <i>ARNTL2</i> overexpression reversed the promoting effect of <i>LINC01232</i> knockdown on ferroptosis.<b>Conclusion:</b> <i>LINC01232</i> inhibited the ferroptosis in CRC by epigenetically upregulating the transcriptional activity of <i>ARNTL2</i>.</p>\",\"PeriodicalId\":11959,\"journal\":{\"name\":\"Epigenomics\",\"volume\":\"16 15-16\",\"pages\":\"1097-1115\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11418281/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Epigenomics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/17501911.2024.2387528\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/9/13 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"GENETICS & HEREDITY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Epigenomics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/17501911.2024.2387528","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/9/13 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0

摘要

目的:本研究探讨了lncRNA LINC01232在结直肠癌(CRC)铁变态反应中的作用:实时定量聚合酶链反应或 Western 印迹实验检测相关 mRNA 和蛋白质的表达。试剂盒测定评估丙二醛、铁、Fe2+ 和谷胱甘肽水平。流式细胞术验证了 ROS 水平。染色质免疫共沉淀和 RNA 免疫共沉淀分析监测了 LINC01232、H3K27ac、p300 和 ARNTL2 之间的相关性:结果:LINC01232或ARNTL2的敲除促进了麦拉宁诱导的铁蛋白沉积。LINC01232和p300之间的相互作用提高了ARNTL2启动子上的H3K27ac水平,从而促进了ARNTL2的转录活性。ARNTL2的过表达逆转了LINC01232敲除对铁突变的促进作用:结论:LINC01232通过表观遗传学方式上调ARNTL2的转录活性,抑制了CRC的铁变态反应。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
LINC01232 promotes ARNTL2 transcriptional activation and inhibits ferroptosis of CRC cells through p300/H3K27ac.

Aim: This study investigated the role of lncRNA LINC01232 in ferroptosis of colorectal cancer (CRC).Materials & methods: Real time quantitative polymerase chain reaction or western blot experiments were performed to examine relevant mRNAs and proteins expression. The kit assays evaluated malondialdehyde, iron, Fe2+ and glutathione levels. ROS levels were verified by flow cytometry. Chromatin immunoprecipitation and RNA immunoprecipitation analysis monitored the correlation among LINC01232, H3K27ac, p300 and ARNTL2.Results: LINC01232 or ARNTL2 knockdown facilitated erastin-induced ferroptosis. The interaction between LINC01232 and p300 resulted in the enhancement of H3K27ac levels at ARNTL2 promoter to promote ARNTL2 transcriptional activity. ARNTL2 overexpression reversed the promoting effect of LINC01232 knockdown on ferroptosis.Conclusion: LINC01232 inhibited the ferroptosis in CRC by epigenetically upregulating the transcriptional activity of ARNTL2.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Epigenomics
Epigenomics GENETICS & HEREDITY-
CiteScore
5.80
自引率
2.60%
发文量
95
审稿时长
>12 weeks
期刊介绍: Epigenomics provides the forum to address the rapidly progressing research developments in this ever-expanding field; to report on the major challenges ahead and critical advances that are propelling the science forward. The journal delivers this information in concise, at-a-glance article formats – invaluable to a time constrained community. Substantial developments in our current knowledge and understanding of genomics and epigenetics are constantly being made, yet this field is still in its infancy. Epigenomics provides a critical overview of the latest and most significant advances as they unfold and explores their potential application in the clinical setting.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信